Home
>
National Drug Code (NDC)
>
Clindamax
Clindamax - 0462-0277-40 - (Clindamycin Phosphate)
Drug Information of Clindamax
| Product NDC: | 0462-0277 |
| Proprietary Name: | Clindamax |
| Non Proprietary Name: | Clindamycin Phosphate |
| Active Ingredient(s): | 20 mg/g & nbsp; Clindamycin Phosphate |
| Administration Route(s): | VAGINAL |
| Dosage Form(s): | CREAM |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Clindamax
| Product NDC: | 0462-0277 |
| Labeler Name: | PHARMADERM. A division of Nycomed US Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA065139 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20091029 |
Package Information of Clindamax
| Package NDC: | 0462-0277-40 |
| Package Description: | 40 g in 1 TUBE, WITH APPLICATOR (0462-0277-40) |
NDC Information of Clindamax
| NDC Code | 0462-0277-40 |
| Proprietary Name | Clindamax |
| Package Description | 40 g in 1 TUBE, WITH APPLICATOR (0462-0277-40) |
| Product NDC | 0462-0277 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Clindamycin Phosphate |
| Dosage Form Name | CREAM |
| Route Name | VAGINAL |
| Start Marketing Date | 20091029 |
| Marketing Category Name | ANDA |
| Labeler Name | PHARMADERM. A division of Nycomed US Inc. |
| Substance Name | CLINDAMYCIN PHOSPHATE |
| Strength Number | 20 |
| Strength Unit | mg/g |
| Pharmaceutical Classes | Decreased Sebaceous Gland Activity [PE],Lincosamide Antibacterial [EPC],Lincosamides [Chemical/Ingredient] |
